Effects of antenatal magnesium sulfate therapy on cerebral and systemic hemodynamics in preterm newborns

References

• Del Moral T, Gonzalez-Quintero VH, Claure N, Bancalari E. Antenatal exposure to magnesium sulphate and the incidence of patent ductus arteriosus in extremely low birth weight infant. J Perinatol. 2007;27:154–7.
   PubMed Web of Science ®Google Scholar
• Tanaka S, Sameshima H, Ikenoue T, Sakamoto H. Magnesium sulfate exposure increases fetal blood flow redistribution to the brain during acute non-acidemic hypoxemia in goats. Early Hum Dev. 2006;82:597–602.
   Google Scholar
• Marret S, Marpeau L, Zupan-Simunek V, Eurin D, Lévêque C, Hellot MF, Magnesium sulphate given before very-preterm birth to protect infant brain: the randomized controlled PREMAG trial. BJOG. 2007;11:310–8.
   Google Scholar
• Marret S, Doyle LW, Crowther CA, Middleton P. Antenatal magnesium sulphate neuroprotection in the preterm infant. Semin Fetal Neonatal Med. 2007;12:311–7.
   PubMed Web of Science ®Google Scholar
• Nassar AH, Sakhel K, Maarouf H, Naassan GR, Usta IM. Adverse maternal and neonatal outcome of prolonged course of magnesium sulfate tocolysis. Acta Obstet Gynecol Scand. 2006;85:1099–103.
   PubMed Web of Science ®Google Scholar
• Mittendorf R, Dambrosia J, Pryde PG, Lee KS, Gianopoulos JG, Besinger RE, Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. Am J Obstet Gynecol. 2002;186:1111–8.
   PubMed Web of Science ®Google Scholar
• Crowther CA, Hiller JE, Doyle LW, Haslam RR. Effect of magnesium sulfate given for neuroprotection before preterm birth. JAMA. 2003;290:2669–76.
   PubMed Web of Science ®Google Scholar
• Rantonen T, Kaapa P, Gronlund J, Ekblad U, Helenius H, Kero P, Maternal magnesium sulfate treatment is associated with reduced brain-blood flow perfusion in preterm infants. Crit Care Med. 2001;29:1460–5.
   PubMed Web of Science ®Google Scholar
• Satake K, Lee JD, Uzui H, Mitsuke Y, Yue H. Effect of magnesium on prostacyclin synthesis and intracellular free calcium concentration in vascular cells. Magnes Res. 2004;24:465–6.
   Google Scholar
• Couture A, Veyrac C, Baud C, Saguintaah M, Ferran JL. Advanced cranial ultrasound: transfontanellar Doppler imaging in neonates. Eur Radiol. 2001;11:2399–410.
   Google Scholar
• Papile LS, Burstein J, Burstein R, Keffler H. Incidence and evaluation of the subependymal intraventricular hemorrhage: a study of infants weighting less than 1500 grams. J Pediatr. 1978;92:529–34.
   PubMed Web of Science ®Google Scholar
• Jonson GL, Breart GL, Gewitz MH, Brenner JL, Lang P, Dooley KJ, Echocardiographic characteristics of premature infants with patent ductus arteriosus. J Pediatr. 1983;72:864–71.
   Google Scholar
• Hirsimaki H, Kero P, Saraste M, Ekblad H, Konvenranata H, Wanne O. Grading of left-to-right shunting ductus arteriosus in neonates with bedside Doppler ultrasound. Am J Perinatol. 1991;8:247–50.
   Google Scholar
• Magpie Trial Follow-Up Study Collaborative Group. The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for children at 18 months. BJOG. 2007;114:289–99.
   PubMed Web of Science ®Google Scholar
• Pride PG, Mittendorf R. Contemporary usage of obstetric magnesium sulfate: indication, contraindication, and relevance of dose. Obstet Gynecol. 2009;114:669–3.
   Google Scholar
• Mercer BM, Merlino AA. Magnesium sulfate for preterm labor and preterm birth. Obstet Gynecol 2009;114:650–68.
   PubMed Web of Science ®Google Scholar
• Limperopoulos C, Gauvreau KK, O'Leary H, Moore M, Bassan H, Eichenwald EC, Cerebral hemodynamic changes during intensive care of preterm infants. J Pediatr. 2008;122:e1006–13.
   Google Scholar
• Constantine MM, Weiner SJ. Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants: a meta-analysis. Obstet Gynecol. 2009;114:350–64.
   Google Scholar
• De Hann HH, Gunn AJ, Gluckman PD. Experiments in perinatal brain injury: what have we to learn? Prenat Neonat Med. 1996;1:16–25.
   Google Scholar
• Elimian A, Verma R, Ogburn P, Wiencek V, Spitzer A, Quirk JG. Magnesium sulfate and neonatal outcomes of preterm neonates. J Matern Fetal Neonatal Med. 2002;12:118–22.
   PubMedGoogle Scholar
• Pezzati M, Giani T, Gambi B, Dani C, Betini G, Biagiotti R, Influence of maternal magnesium sulphate and ritodrine treatment on cerebral blood flow velocity of the preterm newborn. Acta Obstet Gynecol Scand. 2001;80:818–23.
   Google Scholar
• Kontos HA, Wei EP, Navari RM, Levasseur JE, Rosenblum WI, Patterson JL Jr. Responses of cerebral arteries and arterioles to acute hypotension and hypertension. Am J Physiol. 1979;234:H371–83.
   Google Scholar
• Mercer BM, Merlino AA. Magnesium Sulfate for Preterm Labor and Preterm Birth. Obstet Gynecol. 2009;114:650–68.
   PubMed Web of Science ®Google Scholar
• Macones GA. MgSO4 for CP prevention: too good to be true? Am J Obstet Gynecol. 2009;200:589–94.
   Google Scholar
• Doyle LW, Crowther CA, Middleton P, Marret S, Rouse D. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev. 2009:CD004661.
   PubMedGoogle Scholar
• Conde-Agudelo A, Romero R. Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks' gestation: a systematic review and metaanalysis. Am J Obstet Gynecol. 2009;200:595–609.
   PubMed Web of Science ®Google Scholar